CT
Corner Therapeutics, Inc.
SEC filingPharmaceuticals · Watertown, MA
Amount raised$16.8Msold at filing
Total offering$16.8M
Investors in the raise4count reported to the SEC
FiledOct 20, 2025first sale Sep 26, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Alan EzekowitzDirector
Nick SeaverExecutive Officer, Director
Jonathan KaganExecutive Officer, Director
Steven AltschulerExecutive Officer, Director
Richard MalleyDirector
Andrew BellingerDirector
Andrew CornforthExecutive Officer
Garrett NicholsExecutive Officer
Executive officers, directors and promoters as listed on the Form D.